CORNEAGEN INC. – Trademark Portfolio
Entity Type: 03
CORNEAGEN INC. owns a portfolio of 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as CTAK, KAMRA, DESCEPRO, CORNEAGEN, and NANO-THIN. Of these, 10 are registered. The portfolio spans 6 Nice Classification classes, led by Class 10 (Medical Apparatus) and Class 5 (Pharmaceuticals). Headquartered in SEATTLE, WA.
1200 6TH AVENUE, SUITE 300
SEATTLE, WA 98101
Showing of trademarks Trademarks
Trademark Classifications
CORNEAGEN INC.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does CORNEAGEN INC. have?
CORNEAGEN INC. has 17 U.S. trademarks filed with the USPTO. Of these, 10 registered, 4 abandoned, 3 cancelled.
What trademark classes does CORNEAGEN INC. file in?
CORNEAGEN INC. files trademarks across 6 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 1 (Chemicals), Class 35 (Advertising & Business). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are CORNEAGEN INC.'s most well-known trademarks?
CORNEAGEN INC.'s registered trademark portfolio includes well-known marks such as CTAK, KAMRA, DESCEPRO, CORNEAGEN, and NANO-THIN. These are among 10 currently registered trademarks in the portfolio.
What is CORNEAGEN INC.'s trademark registration success rate?
CORNEAGEN INC. has a 59% trademark registration rate, with 10 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.